With a revenue increase of 28.03% in the second quarter 2026, year on year to cumulative value of $37 million, Electrocore Inc 's revenue per employee grew on a trailing twelve months basis to $ 440,084, this marks a new company high. Within the Healthcare sector Employees of 224 other companies have achieved higher revenue per employee. While Electrocore Inc 's total ranking has deteriorated compared to the previous quarter from 1528 to 1902. Electrocore Inc has 83 employees.
As the trend towards direct-to-consumer medical devices gains momentum, Electrocore Inc. has positioned itself at the forefront of this burgeoning market. The company s vagus nerve stimulator, Truvaga, is now available for purchase on Amazon, the world s largest retail platform, marking a significant step in expanding consumer access to neurostimulation technology. The launch comes at a crucial time, signaling investor confidence, as evidenced by a robust stock increase of 12.79% in February 2025.Electrocore’s entry into the e-commerce space is poised to challenge traditional healthcare distribution channels. By enabling consumers to access Truvaga directly, the company is not only simplifying the purchasing process, but also democratizing access to an innovative healthcare solution that aims to alleviate conditions such as migraines and cluster headaches. This strategic move aligns with broader trends in the healthcare sector that favor consumer empowerment and the direct sale of wellness products.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
